AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
McDonald's
MCD
|
+$476M |
| 2 |
JPMorgan Chase
JPM
|
+$361M |
| 3 |
TJX Companies
TJX
|
+$360M |
| 4 |
Medtronic
MDT
|
+$310M |
| 5 |
Philip Morris
PM
|
+$251M |
Top Sells
| 1 |
Wells Fargo
WFC
|
+$491M |
| 2 |
Citigroup
C
|
+$369M |
| 3 |
Kroger
KR
|
+$338M |
| 4 |
Exxon Mobil
XOM
|
+$286M |
| 5 |
Goldman Sachs
GS
|
+$273M |
Sector Composition
| 1 | Financials | 15.76% |
| 2 | Technology | 15.37% |
| 3 | Healthcare | 13.85% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Industrials | 10.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Barclays
BCS
$72.8B
| $440K | ﹤0.01% |
43,685
-1,910
| -4% | -$19.2K |
|
2627
Celldex Therapeutics
CLDX
$1.66B
| $439K | ﹤0.01% |
11,861
+4,067
| +52% | +$151K |
|
|
SPWR
2628
DELISTED
SunPower Corporation Common Stock
SPWR
| $438K | ﹤0.01% |
71,616
+8,566
| +14% | +$52.4K |
|
|
CTRL
2629
DELISTED
Control4 Corporation
CTRL
| $437K | ﹤0.01% |
+22,300
| New | +$437K |
|
2630
Entravision Communication
EVC
$218M
| $432K | ﹤0.01% |
65,400
| – | – |
|
|
REV
2631
DELISTED
Revlon, Inc.
REV
| $429K | ﹤0.01% |
18,100
+8,600
| +91% | +$204K |
|
|
NXRT
2632
NexPoint Residential Trust
NXRT
$864M
| $428K | ﹤0.01% |
17,190
+2,260
| +15% | +$56.3K |
|
2633
Sunrun
RUN
$3.87B
| $425K | ﹤0.01% |
59,700
+12,400
| +26% | +$88.3K |
|
|
TELL
2634
DELISTED
Tellurian Inc.
TELL
| $425K | ﹤0.01% |
+42,400
| New | +$425K |
|
|
MRLN
2635
DELISTED
Marlin Business Services Corp
MRLN
| $425K | ﹤0.01% |
16,900
+4,900
| +41% | +$123K |
|
2636
Live Oak Bancshares
LOB
$1.7B
| $424K | ﹤0.01% |
17,500
+3,400
| +24% | +$82.4K |
|
2637
Western Midstream Partners
WES
$14.5B
| $423K | ﹤0.01% |
9,844
+551
| +6% | +$23.7K |
|
|
TTPH
2638
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $422K | ﹤0.01% |
2,960
+190
| +7% | +$27.1K |
|
2639
iShares Core S&P Small-Cap ETF
IJR
$86.7B
| $419K | ﹤0.01% |
5,970
+784
| +15% | +$55K |
|
2640
Costamare
CMRE
$1.46B
| $417K | ﹤0.01% |
57,000
+23,500
| +70% | +$172K |
|
2641
ImmunityBio
IBRX
$2.48B
| $417K | ﹤0.01% |
55,000
+21,200
| +63% | +$161K |
|
|
CONN
2642
DELISTED
Conn's Inc.
CONN
| $417K | ﹤0.01% |
21,830
-15,100
| -41% | -$288K |
|
2643
Invesco QQQ Trust
QQQ
$372B
| $416K | ﹤0.01% |
3,023
+935
| +45% | +$129K |
|
2644
Trupanion
TRUP
$1.87B
| $416K | ﹤0.01% |
18,600
+1,900
| +11% | +$42.5K |
|
2645
Petrobras Class A
PBR.A
$75.1B
| $415K | ﹤0.01% |
55,586
-83,914
| -60% | -$626K |
|
|
DSPG
2646
DELISTED
DSP Group Inc
DSPG
| $415K | ﹤0.01% |
35,800
+12,100
| +51% | +$140K |
|
|
SINA
2647
DELISTED
Sina Corp
SINA
| $414K | ﹤0.01% |
+4,870
| New | +$414K |
|
2648
OneSpan
OSPN
$592M
| $410K | ﹤0.01% |
28,552
+3,400
| +14% | +$48.8K |
|
2649
NeoGenomics
NEO
$1.07B
| $408K | ﹤0.01% |
45,500
+11,700
| +35% | +$105K |
|
2650
Minerva Neurosciences
NERV
$15M
| $408K | ﹤0.01% |
5,763
-1,262
| -18% | -$89.3K |
|